"10.1371_journal.pone.0078712","plos one","2013-11-07T00:00:00Z","M Harunur Rashid; Germano Heinzelmann; Redwan Huq; Rajeev B Tajhya; Shih Chieh Chang; Sandeep Chhabra; Michael W Pennington; Christine Beeton; Raymond S Norton; Serdar Kuyucak","School of Physics, University of Sydney, Sydney, New South Wales, Australia; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, United States of America; Graduate Program in Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, United States of America; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia; Peptides International, Louisville, Kentucky, United States of America","Conceived and designed the experiments: RSN SK. Performed the experiments: MHR GH RH RBT SCC SC MWP. Analyzed the data: MHR GH RH RBT SCC SC CB RSN SK. Contributed reagents/materials/analysis tools: MWP. Wrote the paper: CB MWP RSN SK.","MWP and CB are inventors on a patent (WO2006042151A2) claiming ShK-186 and ShK-192 for immunomodulation. This patent was licensed to Kineta Inc. for developing ShK-186 as a therapeutic for autoimmune diseases. MWP and CB are consultants to Kineta Inc. CB is an academic editor for PLOS ONE. MWP is employed by Peptides International. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","M Harunur Rashid","MHR",10,TRUE,2,7,9,4,TRUE,TRUE,FALSE,0,NA,FALSE
